ARCHIVES

In Brief: $100 Million Being Spent On Interferon In U.S., Rauscher Says; DeVita; Criticism Deserved

This article is from The Cancer Letter archive.

Vol. 06 No. 14 | April 4, 1980

Download PDF Visit The Full Archive

Related Articles

Modeling: Like The Sims But No Graphics

November 26, 2010

NCI Intramural Programs: Clinical Trials Support System Need Attention, report Advises DCS

December 19, 1997

NCI Objects To Fisher As Scientific Director Of NSABP, Threatens To Cut Off Funding

May 6, 1994

NCI Diet Guideline Outlined At Senate Hearing

November 22, 1985

AACR Urges FDA to Regulate High Risk Lab-Developed Tests

September 12, 2014

CMS also decided to cover off-label uses of approved colorectal cancer drugs in clinical trials, and allowed broader use of PET scans.

November 5, 2004